Product Description

This product from a company called Mycelia Extract claims that “mycelium extract has been shown to support a healthy immune system.” Unfortunately, these claims remain unverifiable and due to selling other supplements and beverages by them it’s important that customers read labels thoroughly prior to purchasing these items.

By purchasing, registering, making reservations or participating in programs offered on the OG website that are administered by third parties and providing any personal data through it to those third parties via the OG website, you are providing your consent for them to process this data according to their privacy policies. This data may include but is not limited to your name, address, phone number, email address purchase history as well as other pertinent details.

Organo Gold International, Inc. and Holton Buggs were found guilty of misappropriating AmeriSciences’ distributor network as well as tortious interference with contracts, fraudulent transfer, and unjust enrichment by the Fifth Circuit Court of Appeals, who upheld both jury verdict and final judgment in favor of AmeriSciences – holding them jointly and severally responsible for compensation damages amounting to $3,461,166.

Business Model

Organo Gold Company claims to be a multi-level marketing firm rather than a pyramid scheme, yet closer examination of their business model suggests otherwise. They put greater focus on recruiting salespeople than selling their products, charge high start-up costs and require distributors to attend high-pressure motivational events; additionally their distribution methods may violate anti-pyramid legislation in some countries.

Pyramid schemes differ significantly from multi-level marketing (MLM) companies in that their emphasis lies more on recruiting new members rather than selling its product or service. While a legitimate MLM company uses a network of independent salespeople to sell its product and offers them commission on every sale they make, pyramid scheme structures don’t permit these independent sellers to generate significant income through sales commissions or commissions on product sales.

Appellants assert that the district court made an error when considering Weingust’s testimony at trial. Under Federal Rule of Evidence 702, it considered Weingust’s list as trade secret material that should have been excluded from jury consideration. Weingust used two approaches to estimate its worth; cost and income approaches. His evaluation concluded that its total worth amounted to approximately $3.451 million under both approaches.